Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder.
Mattingly G, Arnold V, Yan B, Yu M, Robertson B. Mattingly G, et al. Among authors: robertson b. J Child Adolesc Psychopharmacol. 2020 Nov;30(9):549-557. doi: 10.1089/cap.2020.0005. Epub 2020 Oct 13. J Child Adolesc Psychopharmacol. 2020. PMID: 33185468 Free PMC article. Clinical Trial.
Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
Weisler RH, Greenbaum M, Arnold V, Yu M, Yan B, Jaffee M, Robertson B. Weisler RH, et al. Among authors: robertson b. CNS Drugs. 2017 Aug;31(8):685-697. doi: 10.1007/s40263-017-0455-7. CNS Drugs. 2017. PMID: 28712074 Free PMC article. Clinical Trial.
SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study.
Brams M, Childress AC, Greenbaum M, Yu M, Yan B, Jaffee M, Robertson B. Brams M, et al. Among authors: robertson b. J Child Adolesc Psychopharmacol. 2018 Feb;28(1):19-28. doi: 10.1089/cap.2017.0053. Epub 2017 Aug 17. J Child Adolesc Psychopharmacol. 2018. PMID: 28816509 Free PMC article. Clinical Trial.
Improved Executive Function in Adults Diagnosed With Attention-Deficit/ Hyperactivity Disorder as Measured by the Brown Attention-Deficit Disorder Scale Following Treatment With SHP465 Mixed Amphetamine Salts Extended-Release: Post Hoc Analyses From 2 Randomized, Placebo-Controlled Studies.
Brown TE, Chen J, Robertson B. Brown TE, et al. Among authors: robertson b. J Atten Disord. 2022 Jan;26(2):256-266. doi: 10.1177/1087054720961819. Epub 2020 Nov 5. J Atten Disord. 2022. PMID: 33150816 Free PMC article. Clinical Trial.
A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Wilens TE, Robertson B, Sikirica V, Harper L, Young JL, Bloomfield R, Lyne A, Rynkowski G, Cutler AJ. Wilens TE, et al. Among authors: robertson b. J Am Acad Child Adolesc Psychiatry. 2015 Nov;54(11):916-25.e2. doi: 10.1016/j.jaac.2015.08.016. Epub 2015 Sep 15. J Am Acad Child Adolesc Psychiatry. 2015. PMID: 26506582 Clinical Trial.
1,355 results